The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 2024 | The expanding role of robotic surgery in oncology
Pompiliu Piso, MD, Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Germany, discusses the increasing use of robotic surgery in various surgical oncology procedures, noting its clear benefits for esophageal and rectal cancer. While short-term improvements are evident, long-term results are still awaited. He emphasizes that robotic surgery is expanding into other areas like breast and thyroid cancer, and is seen as the future of minimally invasive surgery, offering patients better outcomes and improved quality of life. This interview took place at the ESSO 43 congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
